Clinical Trial Update: Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status [Phase 2]

View source ↗

Summary

Phase 2 trial exploring adjustment of chemotherapy duration in follicular lymphoma based on minimal residual disease status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Snippet

Sponsor: Meir Medical Center | Conditions: Follicular Lymphoma | Phase 2 | Status: UNKNOWN